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Abstract
Staphylococcus aureus is a leading cause of community-associated and nosocomial infections. Imperative to the success of S.
aureus is the ability to adapt and utilize nutrients that are readily available. Genomic sequencing suggests that S. aureus has
the genes required for synthesis of all twenty amino acids. However, in vitro experimentation demonstrates that
staphylococci have multiple amino acid auxotrophies, including arginine. Although S. aureus possesses the highly conserved
anabolic pathway that synthesizes arginine via glutamate, we demonstrate here that inactivation of ccpA facilitates the
synthesis of arginine via the urea cycle utilizing proline as a substrate. Mutations within putA, rocD, arcB1, argG and argH
abolished the ability of S. aureus JE2 ccpA::tetL to grow in the absence of arginine, whereas an interruption in argJBCF, arcB2,
or proC had no effect. Furthermore, nuclear magnetic resonance demonstrated that JE2 ccpA::ermB produced 13C5 labeled
arginine when grown with 13C5 proline. Taken together, these data support the conclusion that S. aureus synthesizes
arginine from proline during growth on secondary carbon sources. Furthermore, although highly conserved in all
sequenced S. aureus genomes, the arginine anabolic pathway (ArgJBCDFGH) is not functional under in vitro growth
conditions. Finally, a mutation in argH attenuated virulence in a mouse kidney abscess model in comparison to wild type
JE2 demonstrating the importance of arginine biosynthesis in vivo via the urea cycle. However, mutations in argB, argF, and
putA did not attenuate virulence suggesting both the glutamate and proline pathways are active and they, or their pathway
intermediates, can complement each other in vivo.
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Introduction
Staphylococcus aureus is a common cause of skin and soft tissue
infections; however more serious complications such as bacter-
emia, osteomyelitis, endocarditis, and necrotizing pneumonia can
occur [1]. During infection, S. aureus must catabolize diverse
carbon sources including carbohydrates, proteins and lipids;
therefore, multiple global regulators, including CcpA and CodY,
subsequently regulate carbon flow [2,3,4]. Thus, regulation of
carbon flow through central metabolism and other metabolic
pathways has a direct link to expression and synthesis of virulence
factors [5,6,7].
It has been known for over 70 years that S. aureus exhibits
multiple amino acid auxotrophies, including arginine, valine,
proline, cysteine, and leucine [8,9]. Complicating the picture, in
1937, Gladstone demonstrated that multiple strains of S. aureus
could be trained to grow in a chemically-defined broth lacking all
twenty amino acids through extended incubation [9]. These data
suggested that S. aureus was indeed a prototroph but repressed
biosynthesis of certain amino acids. In support of this, bioinfor-
matic analyses of the S. aureus genome revealed an apparently
complete repertoire of biosynthetic operons needed to synthesize
all 20 amino acids [10]. Included in these are the genes encoding
the arginine biosynthetic pathway argJBCDFGH where arginine is
synthesized from glutamate [11]. This pathway is highly conserved
among a wide array of bacteria, including Escherichia coli, Salmonella
enterica serotype Typhimurium, Proteus mirabilis, Bacillus subtilis, and
Streptomyces clavuligerus among others [12,13,14].
Although B. subtilis synthesizes proline from glutamate
[11,15,16], S. aureus preferentially utilizes arginine rather than
glutamate as a precursor for proline biosynthesis via arginase
(RocF), ornithine aminotransferase (RocD), and P5C reductase
(ProC) [17]. Furthermore, Li and colleagues recently reported that
proline biosynthesis is regulated through CcpA-mediated carbon
catabolite repression at both rocF and rocD [18]. Carbon catabolite
repression allows bacteria to preferentially utilize preferred carbon
sources and therefore increase the organism’s fitness [19]. The
trans-acting carbon catabolite protein CcpA in a complex with Hpr
binds to cis-acting DNA sequences known as catabolite responsive
elements (CRE) [20,21,22,23]. In the presence of a preferred
carbon source, HprK phosphorylates the Ser-46 position of Hpr
and once phosphorylated, Hpr binds to CcpA [23,24,25].
In this study, we utilized genetic and biochemical approaches to
examine arginine auxotrophy in S. aureus. bursa aurealis transposon
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mutagenesis identified CcpA as a regulator of arginine biosynthe-
sis. However, instead of de-repressing the conserved arginine
biosynthesis pathway (ArgJBCDFGH) via glutamate, S. aureus JE2
ccpA synthesized arginine from proline via the urea cycle. To the
best of our knowledge, this is the first report of bacteria utilizing
proline for arginine biosynthesis, which may indicate a predilec-
tion to degrade and utilize proteins rich in proline (i.e. collagen)
during an S. aureus infection for use in arginine biosynthesis.
Utilization of proline to synthesize arginine demonstrates the
resourcefulness of S. aureus and its ability to rapidly evolve to utilize
nutrients that are readily available in the environment.
Results
Arginine Auxotrophy in Staphylococcus aureus
To examine arginine auxotrophy in S. aureus, eighty-two clinical
S. aureus isolates collected from positive blood cultures at the
University of Nebraska Medical Center were grown on Complete
Defined Medium (CDM) with and without arginine. Similar to
observations by Emmett and Kloos, only one S. aureus isolate
(SA2126) had the ability to grow on CDM lacking arginine (CDM-
R) following 48 h incubation, whereas all isolates grew on CDM
containing arginine further confirming the arginine auxotrophic
nature of S. aureus [8]. Furthermore, a community-associated S.
aureus USA300 strain JE2 (Table S1) was unable to grow on CDM-
R following 48 h incubation at 37uC. To extend these observa-
tions, JE2 was grown to stationary phase in CDM broth
(56109 CFU) and plated on CDM-R and CDM lacking proline
(CDM-P). Similar to the observations of Li and colleagues [18], S.
aureus JE2 reverted to proline prototrophy at a rate of 161026;
however, no colonies were isolated on CDM-R following five
experimental attempts. Nevertheless, similar to observations by
Gladstone, slight growth of JE2 was observed following five days of
incubation in CDM-R broth [9]. These observations suggest that
S. aureus has the inherent ability to synthesize arginine upon
extended selection; however, the phenotype is not easily selected
during growth in medium replete with amino acids.
Regulation of Arginine Biosynthesis by Carbon Catabolite
Repression
Based on our observations that growth in CDM-R could be
selected through extended incubation, we hypothesized that
arginine biosynthesis was under transcriptional repression. There-
fore, we screened a random bursa aurealis transposon library to
isolate JE2 mutants able to grow on CDM-R. Two mutants were
isolated that had the ability to grow on CDM-R; subsequent
sequencing of the bursa aurealis insertions found they had inserted
in hprK and ccpA. Both HprK and CcpA function to control carbon
catabolite repression (CCR) in gram-positive bacteria [26].
Therefore, to completely eliminate CCR, a ccpA allelic replace-
ment mutant was generated in JE2 through 80a transduction of
the ccpA::tetL allele from MST14 (kind gift of M. Bischoff). As
predicted, growth analysis in CDM-R demonstrated that JE2
ccpA::tetL enters exponential phase between 7–12 h and reaches a
maximum OD600 of 4.5 after 24 h, whereas no growth was
observed with wild type JE2 in CDM-R (Figure 1). Importantly,
introduction of the ccpA complementation plasmid pNF266
abrogated growth of JE2 ccpA::tetL.
To further support the hypothesis that CCR functions to repress
arginine biosynthesis, JE2 was grown in CDM-R lacking glucose
but containing other, non-preferred carbon sources (Figure 2).
Since CCR is alleviated when S. aureus is grown in media
containing a non-preferred carbon source, it was hypothesized that
JE2 would grow in CDM-R when glucose was replaced with a
secondary carbon source. These experiments demonstrated that
arabinose, sorbitol and pyruvate were able to support growth of
JE2 when added to CDM-R (Figure 2). In contrast, glucose,
fructose, glycerol, sucrose, mannitol, maltose, salicin, gluconic
acid, and ribose were unable to support growth in CDM-R
suggesting these carbohydrates do not derepress CcpA in JE2. In
agreement with our results, Li and colleagues also determined that
replacement of glucose with arabinose or sorbitol abrogated
CcpA-mediated repression in S. aureus Newman and functioned to
activate proline biosynthesis [18]. Overall, these data demonstrate
that CCR functions to repress arginine biosynthesis, suggesting
that arginine biosynthesis is linked to growth in niches where
preferred carbon sources are limited.
Northern Analysis of argJBCDFGH in JE2 ccpA::ermB
Our preliminary data suggested that CCR functioned to repress
an enzymatic step in the conserved arginine biosynthetic pathway
via glutamate [27] (Figure 3). To further address this possibility,
northern blot analysis was performed to address transcriptional
expression of argJBCDFGH in JE2 ccpA::ermB in comparison to
Figure 1. Interruption of ccpA facilitates growth in CDM-R.
Growth analysis of JE2, JE2 ccpA::tetL, and JE2 ccpA::tetL/pNF266 (ccpA
complement) in complete defined medium lacking arginine (CDM-R).
Isolates were grown aerobically using a 10:1 flask to volume ratio. S.
aureus strains containing a functional ccpA are unable to grow in CDM-
R. Data represent means 6 SEM of three independent experiments.
doi:10.1371/journal.ppat.1003033.g001
Author Summary
Although Staphylococcus aureus encodes the highly
conserved arginine biosynthesis pathway via glutamate,
arginine is an essential amino acid. We found that a
mutation in ccpA, a gene encoding a protein facilitating
carbon catabolite repression, mediates arginine biosyn-
thesis under in vitro growth conditions. However, both
genetic and biochemical evidence suggested that a S.
aureus ccpA mutant synthesizes arginine via proline and
the urea cycle, a pathway not demonstrated in bacteria
before. Furthermore, an animal model of S. aureus
infection demonstrated the importance of arginine bio-
synthesis in vivo. This new pathway sheds light on
important host-pathogen interactions and suggests S.
aureus has evolved to address arginine depletion in the
host by synthesizing arginine from a readily available
substrate such as proline.
Arginine Biosynthesis in Staphylococcus aureus
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wildtype JE2. In S. aureus, argDCJB is arranged in an operon
structure, whereas argF is transcribed as a monocistronic unit and
argGH are co-transcribed. JE2 and JE2 ccpA::ermB were grown in
CDM and CDM-R, respectively, to mid-exponential phase and
mRNA was isolated. Utilizing DNA probes specific for each gene
within the conserved pathway, argDCJB and argF expression was
not detected in either JE2 or JE2 ccpA::ermB (Figure 4). However,
although argG and argH transcripts were not detected in JE2, both
transcripts were detected in JE2 ccpA::ermB (Figure 4). Therefore,
although JE2 ccpA::ermB has the ability to grow on media lacking
arginine, this strain does not appear to utilize the conserved
arginine biosynthetic operon to synthesize arginine in CDM-R.
These results suggested the existence of a novel arginine
biosynthetic pathway in S. aureus.
S. aureus Utilizes a Novel Proline Catabolic Pathway to
Synthesize Arginine
Since our data indicated that glutamate was not the precursor
for arginine synthesis in JE2 ccpA::ermB, other potential pathways
were examined in silico. Based on the northern blot data
demonstrating the expression of argGH in JE2 ccpA::ermB, we
hypothesized that arginine may be synthesized via the urea cycle
(Figure 3). In silico analysis predicted that either glutamate or
proline have the potential to feed into the urea cycle to serve as
substrates for arginine biosynthesis. To address this hypothesis, we
examined amino acid consumption by JE2 and JE2 ccpA::ermB
grown in CDM and CDM-R, respectively (Figure S1). These
results demonstrated that both JE2 and JE2 ccpA::ermB consumed
similar amounts of glutamate from the culture media following
24 h of growth. In contrast, JE2 ccpA::ermB consumed all available
free proline from the culture medium, whereas only approximately
50% of the available free proline was consumed by JE2. Taken
together, these observations allowed us to speculate that JE2
ccpA::ermB utilized proline via the urea cycle for arginine synthesis.
To further investigate this hypothesis, Q11 transducing lysates
were prepared from defined JE2 bursa aurealis mutants with
insertions in the following genes: putA, proC, rocD, arcB1, arcB2,
argF, argG, argH, argC, argB and argJ. These bursa aurealis mutations
(conferring erythromycin resistance) were transduced into JE2
ccpA::tetL and subsequently grown in CDM-R (Figure 5). Muta-
tions in argG, argH, putA, rocD, and arcB1 abrogated growth of JE2
ccpA::tetL in CDM-R. However, mutations in argJ, argB, argC, argF,
arcB2, or proC had no effect on growth consistent with the
prediction that arginine is synthesized from proline and not
glutamate (Figure 5).
Two-dimensional (2D) 1H-13C heteronuclear single quantum
coherence (HSQC) nuclear magnetic resonance (NMR) experi-
ments were performed to confirm these data. JE2 and JE2
ccpA::ermB were grown in the presence of 13C5-glutamate or
13C5-
Figure 2. Growth of JE2 in CDM containing non-preferred
carbon sources. JE2 was grown in CDM or CDM-R with the indicated
carbon source at 37uC for 18 hours. Significant growth in CDM-R was
seen only when arabinose and sorbitol were used as carbon sources.
Data represent means 6 SEM of five independent experiments.
doi:10.1371/journal.ppat.1003033.g002
Figure 3. Arginine biosynthetic pathway via glutamate and
proline. Figure depicts highly conserved arginine biosynthetic
pathway via glutamate and the proposed pathway from proline via
PutA, RocD, ArcB1, ArgG and ArgH. Note the previously established
reverse pathway from arginine to proline via RocF, RocD and ProC.
doi:10.1371/journal.ppat.1003033.g003
Figure 4. Northern analysis of arginine biosynthetic pathway in
S. aureus JE2 and JE2 ccpA::ermB. JE2 and JE2 ccpA::ermB total RNA
was isolated in mid-exponential phase of growth in CDM and CDM-R,
respectively. DNA probes specific for argJ, argB, argC, argD, argF, argG,
and argH were labeled with digoxygenin and detected using anti-
digoxigenin-AP Fab fragments (Panel A). Panel B shows 16 s and 23 s
rRNA depicting equal RNA loading.
doi:10.1371/journal.ppat.1003033.g004
Arginine Biosynthesis in Staphylococcus aureus
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proline in CDM and CDM-R, respectively. Based on our genetic
studies, it was predicted that 13C-labeled arginine would only be
detected when JE2 ccpA::ermB was grown in CDM-R containing
13C5-proline. As expected,
13C-labeled arginine was detected when
JE2 ccpA::ermB was propagated in the presence of 13C5-proline but
not with 13C5-glutamate (Figure 6). Collectively, these results
provide strong evidence that proline is the substrate for arginine
biosynthesis in a ccpA genetic background. Furthermore, it is
demonstrated that the highly conserved arginine biosynthetic
pathway via glutamate is inactive under the growth conditions
utilized in the study.
Arginine Auxotrophy in Other Staphylococcus aureus
Strains
To determine whether our data regarding arginine biosynthesis
were specific to the JE2 background, Q11 transducing lysates were
prepared from JE2 bursa aurealis argF and argH mutants and
introduced into RN4220 and Newman ccpA backgrounds. As
previously noted with JE2 ccpA::tetL, an argH mutation abolished
the ability of both RN4220 ccpA::tetL and Newman ccpA::tetL to
grow in CDM-R, whereas a mutation in argF had no effect
(Figure 7). Interestingly, RN4220 has the ability to grow in CDM-
R broth. Subsequent studies demonstrated that RN4220 reverted
to arginine prototrophy at a frequency of 1.661025; however,
sequence analysis of these mutants indicated they did not have
mutations in ccpA, hprK or ptsH suggesting weak carbon catabolite
repression in the RN4220 strain background. In addition,
RN4220 argH::QNS was unable to grow in CDM-R broth
whereas a bursa aurealis mutation in argF had no effect on growth
suggesting RN4420 synthesizes arginine from proline but not from
glutamate. Collectively, these data suggest that as a species, S.
aureus has evolved to synthesize arginine via proline when growing
in conditions lacking a preferred carbon source.
Virulence in a mouse kidney abscess model. C57BL/6
mice were inoculated retro-orbitally with 106 CFU of JE2, JE2
argH::QNS, JE2 argC::QNS, JE2 putA::QNS, or JE2 argF::QNS.
The mice were harvested at 20 days and the kidneys were
homogenized and CFU/gram of tissue determined (Figure 8). No
statistical difference was determined between JE2 and JE2
argF::QNS, JE2 argC::QNS, or JE2 putA::QNS. However, a
significant difference was noted between JE2 (mean log10 CFU
of 5.31) and JE2 argH::QNS (mean log10 CFU of 4.21) indicating a
potential function of argH and arginine biosynthesis in abscess
development and persistence.
Discussion
The study of arginine biosynthesis has served as a paradigm for
the regulon concept, originally coined by Maas and Clark, where
the same transcriptional repressor regulates unlinked loci, ArgR
[28]. Based on these studies and over 60 years of research, there
are three established biochemical pathways, all utilizing glutamate
as a substrate, that synthesize arginine in bacteria [27]. These
three pathways primarily differ in the enzymes used to generate L-
citrulline from N-acetyl-L-ornithine [27,29]. All sequenced staph-
ylococcal species analyzed to date encode the highly conserved
ArgJBCDFGH on three separate unlinked transcriptional units;
two operons (argDCJB and argGH) and one monocistronic gene
(argF). Within the S. aureus USA300 FPR_3757 genome
Figure 5. Determination of arginine biosynthesis-dependent
genes in S. aureus JE2 ccpA::tetL. Defined bursa aurealis transposon
mutants in argJ, argB, argC, argF, argG, argH, proC, putA, rocD, arcB1,
and arcB2 were transduced into JE2 ccpA::tetL and assessed for growth
in CDM-R for 18 hours. Data represent means 6 SEM of three
independent experiments.
doi:10.1371/journal.ppat.1003033.g005
Figure 6. Two-dimensional (2D) 1H-13C heteronuclear single
quantum coherence (HSQC) nuclear magnetic resonance
(NMR) analysis of JE2 and JE2 ccpA::ermB. JE2 and JE2 ccpA::ermB
were grown in the presence of 13C5-glutamate or
13C5-proline in CDM
and CDM-R, respectively, and assayed using 2D 13C HSQC NMR. The
differences in 13C-arginine relative intensity were determined by
subtracting the average intensities between JE2 and JE2 ccpA::ermB,
and a student’s t-test was utilized to determine significance. A positive
relative intensity value is indicative of a greater intensity of 13C-arginine
in JE2 ccpA::ermB in comparison to JE2. JE2 ccpA::ermB accumulated
significantly greater amounts of 13C-arginine when grown in CDM
containing 13C5-proline in comparison to JE2. Note that there was no
significant difference in 13C-arginine accumulation between JE2 and JE2
ccpA::ermB when grown in CDM and CDM-R, respectively, containing
13C5-glutamate.
doi:10.1371/journal.ppat.1003033.g006
Arginine Biosynthesis in Staphylococcus aureus
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(NC_007793), the genes predicted to encode the arginine
biosynthetic pathway are as follows: argJ (bifunctional
ornithine acetyltransferase/glutamate N-acetyltransferase),
SAUSA300_0185, EC 2.3.1.35/2.3.1.1; argB (acetylglutamate
kinase), SAUSA300_0184, EC 2.7.2.8; argC (N-acetyl-gamma-
glutamyl-phosphate-reductase), SAUSA300_0186, EC 1.2.1.38;
argD (acetylornithine transaminase), SAUSA300_0187, EC
2.6.1.11; argF (ornithine carbamoyl transferase),
SAUSA300_1062, EC 2.1.3.3; argG (argininosuccinate synthase),
SAUSA300_0864, EC 6.3.4.5; and argH (argininosuccinate lyase),
SAUSA300_0863, EC 4.3.2.1. However, as previously reported
and confirmed in this study, S. aureus is a functional arginine
auxotroph when grown on complex laboratory media [8,9]. In
addition, no nonsense mutations or insertions were detected within
the argJBCDFGH genes of the USA300 FPR_3757 genome or any
other sequenced staphylococcal genome, suggesting that arginine
biosynthesis is not a decaying pathway in the staphylococci. As
discussed by Somerville and Proctor, in some cases, amino acid
auxotrophies in S. aureus may be linked to TCA cycle inactivity or
feedback inhibition due to growth in amino acid and glucose
replete media [30]. Our results are in agreement with this
hypothesis where inactivation of ccpA, which represses the TCA
cycle [31] and other genes that function to metabolize secondary
carbon sources, was linked to arginine biosynthesis in S. aureus. In
the presence of a preferred carbon source, the CcpA/Hpr
complex represses a multitude of genes linked to central
metabolism, amino acid metabolism and virulence [2,32,33,34].
Therefore, based on previous studies, bioinformatic analyses of the
S. aureus genome, and the work by Li and colleagues demonstrating
that proline biosynthesis was linked to ccpA regulation, it was not
unexpected to discover that arginine biosynthesis was linked to
carbon catabolite repression [5,18,30,35]. However, it was
remarkable to discover that S. aureus does not use the conserved
argJBCDFGH pathway to synthesize arginine via glutamate.
Rather, we provide both genetic and biochemical evidence in
support of a novel biosynthetic pathway, whereby S. aureus utilizes
proline as a substrate via the urea cycle. First, mutations within
putA, rocD, arcB1, argG, and argH, but not argJ, argB, argC, or argF,
abolished growth of a ccpA mutant on CDM-R, providing genetic
evidence that proline serves as a precursor for arginine synthesis
(Figure 5). It is important to note that inactivation of arcB1
abrogated growth of JE2 ccpA::tetL whereas a mutation in arcB2 did
not. arcB1 (SAUSA300_2569) encodes the native ornithine
carbamoyltransferase within the arginine deiminase operon
whereas arcB2 (SAUSA300_0062; ornithine carbamoyltransferase)
is within the ACME pathogenicity island encoded arginine
deiminase operon [36]. These data suggest that ArcB1 and ArcB2
are not functionally redundant or are not expressed under the
same growth conditions. arcB2 transcript is not detected using
northern analysis (data not shown) under in vitro growth conditions
used in this study (CDM or CDM-R broth), however, it is
unknown whether it is induced under other in vivo or in vitro growth
conditions. Second, 2D 1H-13C HSQC NMR experiments
provided compelling evidence that arginine is synthesized via
proline and the urea cycle in a S. aureus ccpA mutant. Although
there have been two reports demonstrating that proline is
synthesized from arginine in S. aureus [17,18], we are unaware of
any reports demonstrating that arginine can be synthesized from
proline. Li and colleagues demonstrated that CcpA binds to a cre
site just upstream of rocD. Using the cre site from pckA as a
consensus sequence [18], we identified potential cre sites upstream
of putA, arcB1, and argGH (Figure S2). However, the function of
these cre sites in regards to CcpA regulation has yet to be defined.
Previous studies have demonstrated that a S. aureus ccpA mutant
also synthesizes proline from arginine via RocF (arginase), RocD
(ornithine aminotransferase), and ProC (P5C reductase) [17,18].
Figure 7. Determination of arginine biosynthesis-dependent
genes in S. aureus Newman and RN4220. Defined bursa aurealis
transposon mutants in argF and argH were transduced into Newman
ccpA::tetL and RN4220 ccpA::tetL and assessed for growth in CDM-R for
18 hours. Data represent means 6 SEM of three independent
experiments.
doi:10.1371/journal.ppat.1003033.g007
Figure 8. Mouse kidney abscess model. C57BL/6 mice were
infected with 106 CFU of JE2 (n = 16 mice), JE2 argF::QNS (n = 14 mice),
JE2 argH::QNS (n = 15 mice), JE2 argC::QNS (n = 13 mice), or JE2
putA::QNS (n = 18 mice). Kidneys were homogenized after 20 days and
bacterial burden determined through viable count (CFU/gram tissue).
Horizontal line represents median log10 CFU/gram; significant differ-
ences in bacterial burden were noted between JE2 and JE2 argH::QNS
(**p,.01). Data were analyzed using two-way ANOVA.
doi:10.1371/journal.ppat.1003033.g008
Arginine Biosynthesis in Staphylococcus aureus
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Collectively, these data and our observations suggest that under
carbon-limiting conditions (in vivo environment), S. aureus can
synthesize proline from arginine and arginine from proline
depending on which amino acid is limited. Based on our findings
and the existing literature, we propose a hypothetical model
whereby free arginine is limited in the host during infection
causing competition between the host and bacteria for arginine. In
humans, L-arginine is a non-essential amino acid under homeo-
static conditions. However, arginine becomes a ‘‘conditionally
essential’’ [37] amino acid during sepsis or trauma due to its use as
a substrate for inducible nitric oxide synthase [38] and function in
cell-mediated immunity [39], protein synthesis [40] and wound
healing [41,42]. Indeed, recent studies have shown significant
iNOS and arginase expression during S. aureus infection [43]
(Figure 9), providing further support that a staphylococcal abscess
may be an arginine-depleted environment based on the require-
ment of arginine for these host enzymes to function. In addition,
low levels of L-arginine have been reported in plasma during sepsis
[37], causing some investigators to suggest the use of L-arginine as
a treatment modality [44]. Furthermore, arginine can serve as a
substrate for arginine deiminase and subsequent direct ATP
generation in the staphylococci [27].
Although little information is available regarding the concen-
tration of free proline in a staphylococcal abscess, proline is the
predominant amino acid found in collagen. Collagen is the most
abundant protein in animals and type I collagen is a major
constituent of the fibrotic wall surrounding staphylococcal
abscesses [45] (Figure 9). Furthermore, S. aureus encodes two
proteases, SspB and ScpA, which possess the ability to degrade
collagen [46,47,48]. Therefore, our model predicts that S. aureus
utilizes specific proteases to degrade collagen, resulting in the
liberation of free proline or proline-containing peptides that are
utilized to synthesize arginine via the urea cycle. Strengthening
this argument, earlier work demonstrated that mutants lacking the
high affinity proline permease PutP are less virulent in animal
models of infection [49,50]. This proposed framework was initially
tested using a mouse kidney abscess model previously utilized by
Cheng and colleagues [51]. In this model, staphylococcal abscesses
within the kidney are contained within a pseudocapsule-like
structure; we hypothesized an argH and putA mutant would be
attenuated in abscess persistence in comparison to wild type JE2,
JE2 argC::QNS and JE2 argF::QNS due to the inability to utilize
proline from the pseudocapsule as a substrate for arginine
synthesis. Supporting our model, in those kidneys containing
staphylococcal abscesses, a significant 1 log10 difference was
observed between JE2 and JE2 argH::QNS demonstrating the
importance of arginine biosynthesis via the urea cycle in an in vivo
infection model. As predicted, based on our in vitro data, no
significant difference was observed between JE2, JE2 argC::QNS,
and JE2 argF::QNS in the mouse kidney abscess model. However,
in contrast to our predicted results, no significant difference in
bacterial persistence was detected between JE2 and JE2 putA::
QNS; PutA converts proline into pyrolline-5-carboxylate
(Figure 3). It is known that the addition of either citrulline or
ornithine to CDM-R can complement JE2 ccpA::tetL putA::QNS
allowing growth. Therefore, it is possible that generation of
citrulline or ornithine by arginine deiminase and ornithine
carbamoyltransferase [27], respectively, circumvents and comple-
ments the proline requirement and facilitates the synthesis of
arginine. In addition, since argGH is common to both the
glutamate and proline pathways leading to the synthesis of
arginine, an alternative interpretation of the data is that both
pathways are active in vivo and have the ability to complement
each other.
Finally, we have demonstrated that other S. aureus strains
synthesize arginine from proline when CcpA activity is abolished,
suggesting conservation of this pathway within the species.
However, based on the conserved sequence analysis of the
ArgJBCDFGH pathway within sequenced S. aureus isolates, we
predict that this arginine biosynthetic pathway is active under
growth conditions or niches that remain to be identified. Further
work is required to dissect the evolving dogma regarding arginine
metabolism and the relationship between the host and S. aureus in
the ‘‘war for arginine’’ during infection.
Materials and Methods
Ethics
The clinical S. aureus strains used in this study originated from
the University of Nebraska Medical Center. The Institutional
Review Board at the University of Nebraska Medical Center is
charged with reviewing all research involving human subjects. The
clinical S. aureus strains utilized in the study were de-identified and
analyzed anonymously and were therefore exempt from human
research committee approval.
Animal experimentation was performed under a University of
Nebraska Medical Center approved Institutional Animal Care and
Use Committee (IACUC) Protocol to TK. The University of
Nebraska Medical Center is accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care
International (AALAC). In addition, all animals at the University
of Nebraska Medical Center are maintained in accordance with
Figure 9. Mouse subcutaneous abscess model. C57BL/6 flank
abscesses caused by subcutaneous injection of 56105 CFU of S. aureus
JE2. Tissues were processed for immunofluorescence staining for either
type I collagen (red), inducible nitric oxide synthase (iNOS, red), or
arginase (green). In addition to type I collagen, tissues were processed
with the DAPI nuclear stain (blue) to accentuate the abscess core.
Representative confocal microscopy images are presented for type I
collagen (106magnification) and iNOS/arginase (206magnification).
doi:10.1371/journal.ppat.1003033.g009
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the Animal Welfare Act and the DHHS ‘‘Guide for the Care and
Use of Laboratory Animals.’’
Bacterial Strains and Culture Conditions
For determination of arginine auxotrophy, eighty-two S. aureus
isolates were obtained from a previous collection testing the
prevalence of heterogeneous vancomycin intermediate suscepti-
bility [52]. Other bacterial strains used in the study are shown in
Table S1. Defined bursa aurealis transposon mutants were acquired
from the Nebraska transposon mutant library via the Network on
Antimicrobial Resistance in Staphylococcus aureus (NARSA; http://
www.narsa.net). Bacterial strains were grown in either Tryptic Soy
Broth (TSB; Becton Dickinson, Franklin Lakes, NJ) or Complete
Defined Medium (CDM) as previously described except contain-
ing 0.25% glucose [53]. Cultures were grown aerobically (1:10
volume to flask ratio) at 37uC, 250 rpm unless otherwise stated. To
train JE2 to grow on media lacking arginine, cultures were grown
in CDM-R broth for 6 days, at which point the bacteria were
inoculated to CDM-R agar. To study the reversion frequency of
JE2, Newman and RN4220, the bacteria were grown for 20 hours
in 3 mL of CDM. Cells were pelleted, resuspended in 0.9% NaCl,
and diluted onto CDM, CDM-R, or CDM-P. After 72 hours the
colonies were counted and reversion frequency was determined by
taking the number of prototrophic revertants divided by total
number of colonies plated on CDM.
To determine the growth characteristics in CDM-R containing
various alternative carbon sources, JE2 was grown in 3 mL of
CDM overnight, pelleted and resuspended in 0.9% NaCl. 3 mL of
CDM and CDM-R supplemented with either 0.25% of glucose,
fructose, glycerol, sucrose, mannitol, maltose, salicin, gluconic
acid, arabinose, sorbitol, or ribose (all purchased from Sigma-
Aldrich, St. Louis, MO) were inoculated in a 14 mL polypropyl-
ene round-bottom tube (Becton Dickinson) to an OD600 of 0.05.
Cultures were grown for 18 h at 37uC to stationary phase.
Screening of Random bursa aurealis Transposon Mutant
Library
Random bursa aurealis transposon mutants were generated using
plasmids pBursa and pFA545 and identified using inverse PCR as
previously described [54]. Mutants were grown and collected in a
96 well format and pelleted and resuspended in 50 uL of 0.9%
NaCl. 2 uL were plated on CDM and CDM-R and incubated at
37uC for 72 hours. Approximately 2700 mutants were screened;
colonies that grew on CDM-R plates were confirmed by growing
in CDM-R broth.
Transduction, ccpA Mutant Construction and
Complementation
bursa aurealis transposon mutations were moved to other strain
backgrounds through transduction using phage 80a or Q11 as
previously described [55]. All primers (Table S2) used for
construction and confirmation of the ccpA mutation were generated
based on the sequence of S. aureus strain Mu50 (NC_002758.2). The
ccpAmutant was constructed by replacing a 0.6 kb internal region of
the ccpA gene with an erythromycin resistance cassette (ermB) using
the gene splicing by overlap extension (gene SOEing) technique
[56]. ermB was amplified from pEC4 [57] using primers SAV1736-
ermB-f and SAV1736-ermB-r, which contain sequences homolo-
gous to the ccpA gene. Primers BamHI-SAV1737-f and ermB-
SAV1736-r were used for amplification of a 1.3 kb region upstream
of the ccpA gene. Primers ermB-SAV1736-f and SacI-acuC-f were
used to amplify a 1.7 kb region downstream of the ccpA gene. The
resulting 4.1-kb PCR product contained BamHI and SacI sites that
were used for cloning into pTS1-d [58] to generate plasmid
pMRS44. Plasmid pMRS44 was used to construct S. aureus SA564
ccpA::ermB using the temperature shift protocol as previously
described [59]. Allelic replacement of the internal region of the
ccpA gene by the ermB cassette was verified by PCR using primers
ermB-f, ermB-r, SAV1737-f and acuC-f. The ccpA::ermB mutation
was subsequently moved to JE2 through phage 80a transduction
and confirmed using primers noted above. For the ccpA comple-
mentation plasmid pNF266, ccpA was amplified from JE2 using
primers 2250 and 2251 (Table S2), digested with SphI and BamHI,
and cloned into pCN51 [60]. Note that two ccpA mutants were
constructed in this study, JE2 ccpA::ermB and JE2 ccpA::tetL. JE2
ccpA::tetL was generated by phage 80a transduction of the ccpA::tetL
allele from MST14 [2] so double mutants could be constructed
using ermB as the second selectable marker.
NMR Data Collection
JE2 and JE2 ccpA::ermB were grown in 50 mL CDM to stationary
phase. JE2 and JE2 ccpA::ermB were subsequently inoculated to an
OD600 of 0.05 in CDM containing 100 mM of either 13C5-
glutamate or 13C5-proline (Isotec) and grown to stationary phase.
Cultures were normalized to an OD600 of 2.0 and pelleted by
centrifugation (3000 rpm, 20 minutes, 4uC). Pellets were subse-
quently washed in 10 mL of cold sterile water and resuspended in
1 mL cold sterile water. The Pellet was lysed using a bead beater
(MP Biomedicals) and centrifuged for 15 minutes at 13,000 rpm at
4uC. This lysis step was repeated two more times and the pellet
frozen in an ethanol/dry ice bath. The samples were then
lyophilized, suspended in 600 uL of 50 mM phosphate buffer
(pH=7.2, uncorrected) in 99.8% D2O (Isotec), and transferred to
5 mmNMR tubes for analysis. The NMR spectra were collected on
a Bruker 500 MHz Avance spectrometer equipped with a triple-
resonance, Z-axis gradient probe. A BACS-120 sample changer
with Bruker Icon software was used to automate the NMR data
collection. The 2D 1H-13C HSQC spectra were collected with a
standard Bruker pulse sequence (HSQCETGP), solvent presatura-
tion and a relaxation delay of 1.5s. Each 2D 1H-13C HSQC
spectrum was collected with a spectrum width of 4734.85 Hz and
2048 data points in the direct (1H) dimension; and a spectrum width
of 13834.26 Hz and 64 data points in the indirect (13C) dimension.
A total of 16 dummy scans and 128 scans were used to obtain each
2D 1H-13C HSQC spectra.
The spectra were processed using the NMRPipe software
package [61]. The spectra were Fourier transformed, manually
phased, and baseline corrected. The processed 2D 1H-13C HSQC
spectra were then analyzed using NMRView [62] to assign
chemical shifts and intensities to each peak. The chemical shift list
were assigned to specific metabolites using the Human Metaba-
lome Database [63], Madison Metabolomics Database [64], and
Platform for Riken Metabolomics [65] with a tolerance level of
0.05 ppm and 0.40 ppm in the 1H and 13C chemical shifts
respectively. The presence of metabolites and metabolomics
pathways was verified using the Kyoto Encyclopedia of Genes
and Genomes (KEGG) [66] and MetaCyc [67] databases. The
quantification of metabolomic peak intensities were performed in a
similar manner as previously described [68]. The relative percent
concentration difference was determined by subtracting averages
from the two cultures. A student T-test was performed to verify the
significance at a 95% confidence level, of the relative percent
concentration differences.
RNA Isolation and Northern Blot Analysis
Cultures of S. aureus JE2 and JE2 ccpA::ermB were grown
overnight in CDM, diluted to an OD600 of 0.05 into fresh CDM or
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CDM-R (1:10 volume to flask ratio, 250 rpm), and grown at 37uC
to an OD600 of 1.5 (mid-exponential growth). Cells were pelleted
at 30006g for 20 minutes at 4uC and resuspended in RLT buffer
with 1% b-mercaptoethanol. Next, they were transferred to lysing
matrix B tubes (MP Biomedicals) and processed in a FP120
FastPrep cell disrupter (MP Biomedicals) for 24 seconds at a
setting of 6.0. The cells were pelleted at 13000 rpm at 4uC for
15 minutes; top-phase was combined with 500 uL of ethanol. The
samples were then processed using an RNeasy mini kit, according
to manufactures instructions (Qiagen, Inc.). Primers listed in Table
S2 were used to make DNA probes that were subsequently labeled
with digoxigenin-labeled dUTP (Roche). 5 ug of RNA was used
for northern analysis that was performed using DIG buffers and
washes (Roche). Anti-Digoxigenin-AP Fab fragments (Roche) was
used with ECF substrate (GE Healthcare) for detection. Blots were
visualized using the Typhoon FLA 7000 imaging system (GE
Healthcare).
Amino Acid Analysis
JE2 and JE2 ccpA::ermB were grown overnight in 50 mL
(500 mL flask) of CDM. Cultures were inoculated to a starting
OD600 of 0.05 in CDM (100 mL in 1 L flask, 250 rpm, 37uC) and
grown for 5 hours. 500 uL of media was collected and pelleted for
5 minutes at maximum speed. Supernatant was collected and
filtered through 3,000 MWCO Amicon Ultra centrifugal filters
(Millipore) according to manufactures instructions. Amino acid
analysis was performed by the Protein Structure Core Facility,
UNMC, using a Hitachi L-8800.
Animal Models
Mouse subcutaneous abscess model. Subcutaneous ab-
scesses were established in C57BL/6 mice following the injection
of 56105 cfu of S. aureus JE2. Tissues were collected at day 7 post-
infection and processed for immunofluorescence staining for either
type I collagen (Millipore, Billerica, MA), inducible nitric oxide
synthase (Abcam, Cambridge, MA), or arginase (Santa Cruz, San
Diego, CA.) For type I collagen, tissues were incubated with the
nuclear stain DAPI to accentuate the abscess core. Mouse kidney
abscess model. C57BL/6 mice were anesthetized using ketamine and
xylazine and 100 ml containing 107 CFU of S. aureus JE2, JE2
argH::QNS, or JE2 argF::QNS were inoculated retro-orbitally. On
day 20 following inoculation, the animals were sacrificed and the
kidneys were excised, homogenized, and subsequently plated for
bacteriological analysis (CFU/g of tissue) on Trypticase soy agar
(TSA). Only those kidneys containing greater than 100 CFU/g of
tissue were statistically analyzed. Pairwise comparisons were
conducted and differences were adjusted for multiple comparisons
using the Tukey-Kramer method to maintain an overall
alpha= .05 across all comparisons.
Supporting Information
Figure S1 Amino acid analysis of JE2 and JE2
ccpA::ermB following growth in CDM. JE2 and JE2
ccpA::ermB were grown in CDM for 18 hours and supernatant
was collected and analyzed for amino acid content. Percent of
proline and arginine remaining is shown suggesting more efficient
utilization of proline by JE2 ccpA::ermB in comparison to JE2.
(TIF)
Figure S2 Putative cre sites in arginine biosynthesis-
dependent genes. Using the cre site from pckA as a consensus
sequence, putative cre sites were identified in rocD, arcB1, putA, and
argGH. cre site from pckA is the top sequence whereas the putative
cre site from the identified gene is the bottom sequence.
(TIF)
Table S1 Bacterial Strains and Plasmids used in study.
(DOCX)
Table S2 Oligonucleotides used in study.
(DOCX)
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